期刊文献+

髓样抑制细胞免疫抑制机理的研究 被引量:4

Study on mechanisms of immune suppression mediated by myeloid derived suppressor cells
下载PDF
导出
摘要 目的:研究荷瘤小鼠来源的髓样抑制细胞(Myeloid derived suppressor cell,MDSC)在肿瘤免疫抑制中的作用机理。方法:用Percoll分离法从荷瘤小鼠的脾脏和骨髓中分离Gr-1+CD11b+MDSC;用流式细胞术检测MDSC对T细胞增殖的抑制作用;分别用生化法和ELISA技术检测MDSC体外培养上清中抑制性因子NO、ROS和IL-10、TGF-β的含量。结果:MDSC在荷瘤小鼠的脾脏和骨髓中聚集增多,且其在骨髓中所占的比例显著高于脾脏;MDSC可以明显抑制脾脏细胞的增殖,体外培养6小时的MDSC可以分泌大量NO、ROS和IL-10、TGF-β。结论:本实验进一步证实MDSC可以通过分泌大量NO、ROS和IL-10、TGF-β抑制T细胞增殖。 Objective:To study the mechanisms of immune suppression mediated by Gr-1 + CD11b + myeloid derived suppressor cells (Gr-1 + CD11b+ MDSC) from tumor-bearing mice. Methods: Gr-1+ CD11b+ MDSC recruited into spleen and bone marrow of tumor-bearing mice were purified by Percoll, and suppression mediated by MDSC on T cell proliferation from spleen of naive mice was detected by flow cytometry with CSFE and FITC-anti CD3 staining, and NO, ROS, IL-10 and TGF-β in the supernatant of MDSC were detected by Griess and ELISA. Results:There were much more Gr-1+ CD11b+ MDSCs in spleen and bone marrow from tumor-bearing mouse than those of naive mouse,and suppression on T cell proliferation mediated by MDSC from tumor bearing mouse was significantly increased, and there were much more NO, ROS,IL-10 and TGF-β in the supernatant of these MDSC than that from naive mouse. Conclusion: MDSC from tumor-bearing mice secreted high level of NO,ROS,IL-10 and TGF-β to induce immune suppression,and inhibite the proliferation of T cells.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2010年第1期17-22,共6页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(No.30771976)
关键词 髓样抑制细胞 NO ROS IL-10 TGF-Β MDSC NO ROS IL-10 TGF-β
  • 相关文献

参考文献31

  • 1Firm O J. Cancer vaccines:between the idea and the reality [J] .Nat Rev Immunol,2003; 3(8) :630-641.
  • 2Durra G P, Bruce A T, Lkeda H etal. Cancer immunoediting: from immunosurveillance to tumor escape [ J ]. Nat Immunol, 2002; 3 ( 11 ) : 91-98.
  • 3PardoU D. Does the immune system see tumors as foreign or self ? [ J ]. Annu Rev Immunol, 2003; 21 : 807-839.
  • 4Yang R C,Cai Z, Yuan William H et al. CDS0 in irmmme suppresssion by mouse ovarian carcinoma-associated Gr-1 ^+CD11b^+ myeloid cells [ J ]. Cancer Res,2006;66(13) :6807-6815.
  • 5Vakkila J, Lotze M T. Inflammation and necrosis promote tumor growth [J]. Nat Rev Immunol,2004;4(8):641-648.
  • 6Bronte V, Serafmi P, ApoUoni E etal. Tuner-induced immune dysfunctions caused by myeloid suppressor cells [ J ]. J Immunother, 2001 ; 24 (6) : 431-446.
  • 7Yang L, DeBusk L M, Fukuda K et al. Expansion of myeloid immune suppressor Gr-1 ^+ CD11b+ cells in tuner-bearing host directly promotes tumor angiogenesis[ J]. Cancer Cell,2004;6(4) :409-421.
  • 8Ochoa A C, Zea A, Hemandez C etal. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma[J]. Clin Cancer Res, 2007 ; 13(2) :721-726.
  • 9Sinha P, Clements V K, Ostrand-Rosenberg S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor ceils block immune surveillance against metastasis [ J ]. Cancer Res, 2005 ; 65 ( 24 ) : 11743- 11751.
  • 10Bronte V, Serafini P, De Santo C et al. IL-4-induced arginase 1 suppresses alloreactive T ceils in tumor-bearing mice[ J]. J Immunol, 2003;170(1):270-278.

同被引文献50

  • 1WS299-2008乙型病毒性肝炎诊断标准[S].2009-6-15.
  • 2Dolcetti L, Marigold I, Mantel B, et al. Myeloid-derived suppres- sor cell role in tumor-related inflammation[J]. Cancer Lett, 2008, 267(2) : 216-225.
  • 3Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity[J]. Cancer Im- munol lmmunother, 2010,59(10) :1593.
  • 4Haile LA, Greten TF, Korangy F. Immune suppression: the hall- mark of myeloid derived suppressor cells[J]. Immunol Invest, 2012,41(6-7) :581.
  • 5Talmadge JE,Gabrilovich DI. History of myeloid-derived suppres- sor cells[J]. Nat Rev Cancer,2013,13(10):739.
  • 6Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system[J]. Nat Rev Immunol, 2009,9 (3):162.
  • 7Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice[J]. J Immunol,2008,181 (8) :5791.
  • 8Montero A J, Diaz-Montero CM, Kyriakopoulos CE, et al. Myeloid- derived suppressor cells in cancer patients: a clinical perspective [J]. J Immunother,2012,35(2) : 107.
  • 9Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer pa- tients[J]. Cancer Immunol Immunother,2012,61(2):255.
  • 10Nagaraj S,Gabrilovich DI. Myeloid-derived suppressor cells in hu- man cancer[J]. Cancer J ,2010,16(4) :348.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部